GnRH
MATERIAL AND METHODS: Twenty-one premenopausal women with advanced breast cancer        were randomised to receive the GnRH analog triptorelin (3.75 mg i.m.
MATERIAL AND METHODS: Twenty-one premenopausal  @OBJECT$  with advanced breast cancer        were randomised to  @PREDICAT$  the  @SUBJECT$  analog triptorelin (3.75 mg i.m.